Facts About Drug Litigation

In spite of the best efforts of the medical and academic community, the state and federal government, the public interest sector, and many providers of diet drug products and services, too many consumers continue to make choices that promise miracles that are not achievable and, in many instances, threaten the health of the users. The size of the market for fraudulent diet drug products and services, an estimated five billion dollars annually, supports this conclusion. This occurs among a group of consumers who, on average, have attempted to lose weight two to three different times using different methods. Some providers of diet drug products and services argue that dieters are very sophisticated consumers, and, through the experience of several attempts at weight loss, know what works for them and what does not.

Click here for a free case review.

The 1990s saw the emergence of prescription diet drug therapy for overweight/obesity as a potent marketing force rivaling the appeal of commercial weight loss centers and causing some of the largest and most market-driven programs to include a drug therapy component. Some of the most popular weight-loss drugs include:

• Orlistat (Xenical)
• Sibutramine (Meridia)
• Fluoxetine (Prozac)
• Bupropion (Wellbutrin)
• Topiramate (Topamax)
• Sertraline (Zoloft)
• Zonisamide (Zonegran)
• Phentermine
• Diethylpropion.

Most of the drugs can produce modest weight loss when combined with dietary recommendations. The amount of weight lost on each drug varies. Research concludes that the loss attributed to the drugs is slightly less than 11 pounds at the one-year mark.

Click here to contact a Diet Drug Lawyer.